CTOs on the Move

Blueshift

www.blueshift.com

 
San Francisco based Blueshift is the leader in AI-Powered Marketing and is recognized by Gartner as Cool Vendor in this category. Using patented technology, Blueshift`s AI enables consumer marketers at companies like LendingTree, Udacity, IAC, and BBC to activate customer data and launch 1:1 engagement on every channel. Blueshift`s recent innovations in AI-Powered Marketing include AI-Powered Customer Journeys a next generation solution that enables marketers to deliver content rich & personalized customer engagement.
  • Number of Employees: 100-250
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

Blueshift raised $15M on 04/23/2019
Blueshift raised $30M on 02/24/2021

Similar Companies

Sysix Technologies

Slide UX

We started Slide UX to support the product teams and marketers who want to be sure their sites, mobile applications are useful, usable, good-looking, and optimized. Our focus is on user interface design - iterative wireframing, rapid prototyping, and visual design - but we often begin a lot earlier, with generative user research, persona development, requirements definition, experience mapping, and information architecture. And we hang around to clean up the job with tasks like pattern library development, usability testing, and conversion optimization.

Jill Knittel

Executive Strategies helping people find their career path by pairing them up with companies using our professional search tool and staffing solutions.

QuickNode

Run Ethereum, Polygon, Bitcoin, Optimism, Fantom, Solana, Celo, Terra, Arbitrum, BSC & xDai nodes. Access MainNet or TestNet instantly via our API for free!

PCCI

PCCI is a non-profit research and development corporation in Dallas, Texas that specializes in real-time predictive and surveillance analytics for healthcare. Our software interprets EMR data in real-time, transforming them into useful intervention warning tools that assist physicians and hospitals on complex clinical decisions in every field of medicine. We are now expanding these technologies for all conditions and for the benefit of patients in hospitals throughout the world.